[Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis].
about
Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutationsInhibition of lung adenocarcinoma cells by insulin-like growth factor-I receptor and Kirsten rat sarcoma mutations: A mutation analysis with antisense oligodeoxynucleotide.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidenceCancer genes in lung cancer: racial disparities: are there any?EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients
P2860
[Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis].
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
[Comparison of EGFR and KRAS s ...... tic review and meta-analysis].
@en
[Comparison of EGFR and KRAS s ...... tic review and meta-analysis].
@nl
type
label
[Comparison of EGFR and KRAS s ...... tic review and meta-analysis].
@en
[Comparison of EGFR and KRAS s ...... tic review and meta-analysis].
@nl
prefLabel
[Comparison of EGFR and KRAS s ...... tic review and meta-analysis].
@en
[Comparison of EGFR and KRAS s ...... tic review and meta-analysis].
@nl
P2093
P2860
P1476
[Comparison of EGFR and KRAS s ...... tic review and meta-analysis].
@en
P2093
Chengbo Han
Huawei Zou
Jianzhu Zhao
P2860
P304
P356
10.3779/J.ISSN.1009-3419.2010.09.09
P407
P577
2010-09-01T00:00:00Z